• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    5.64 Down 0.23(3.92%) Feb 27, 4:00PM EST
    |After Hours : 5.65 Up 0.01 (0.09%) Feb 27, 4:32PM EST
    Add to Portfolio
    Prev Close:5.87
    Open:5.86
    Bid:N/A
    Ask:6.95 x 2000
    1y Target Est:10.71
    Beta:2.68
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:5.60 - 5.86
    52wk Range:3.11 - 7.82
    Volume:1,802,447
    Avg Vol (3m):2,347,770
    Market Cap:696.31M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREXDown 3.92%696.31M
    ABTDown 0.50%71.33B
    GSKDown 0.88%114.07B
    RHHBYUp 0.80%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Mar-15) :-0.17
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-0.53

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback